| Sox1 maintains the undifferentiated state of cortical neural progenitor cells via the suppression of Prox1-mediated cell cycle exit and neurogenesis M Elkouris, N Balaskas, M Poulou, PK Politis, E Panayiotou, S Malas, ... Stem Cells 29 (1), 89-98, 2011 | 82 | 2011 |
| Sox1 is required for the specification of a novel p2-derived interneuron subtype in the mouse ventral spinal cord H Panayi, E Panayiotou, M Orford, N Genethliou, R Mean, G Lapathitis, ... Journal of Neuroscience 30 (37), 12274-12280, 2010 | 77 | 2010 |
| Adult spinal cord ependymal layer: a promising pool of quiescent stem cells to treat spinal cord injury E Panayiotou, S Malas Frontiers in physiology 4, 340, 2013 | 40 | 2013 |
| Intraperitoneal melatonin is not neuroprotective in the G93ASOD1 transgenic mouse model of familial ALS and may exacerbate neurodegeneration E Dardiotis, E Panayiotou, ML Feldman, A Hadjisavvas, S Malas, I Vonta, ... Neuroscience Letters 548, 170-175, 2013 | 24 | 2013 |
| SOX1 links the function of neural patterning and Notch signalling in the ventral spinal cord during the neuron-glial fate switch N Genethliou, E Panayiotou, H Panayi, M Orford, R Mean, G Lapathitis, ... Biochemical and biophysical research communications 390 (4), 1114-1120, 2009 | 21 | 2009 |
| C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar Aβ amyloid and preserves memory in a mouse model of familial Alzheimer’s disease E Panayiotou, E Fella, S Andreou, R Papacharalambous, P Gerasimou, ... PLoS One 14 (12), e0225417, 2019 | 20 | 2019 |
| Epidemiology of ATTRV30M neuropathy in Cyprus and the modifier effect of complement C1q on the age of disease onset S Andreou, E Panayiotou, K Michailidou, P Pirpa, A Hadjisavvas, ... Amyloid 25 (4), 220-226, 2018 | 20 | 2018 |
| Vsx1 transiently defines an early intermediate V2 interneuron precursor compartment in the mouse developing spinal cord C Francius, M Hidalgo-Figueroa, S Debrulle, B Pelosi, V Rucchin, ... Frontiers in molecular neuroscience 9, 145, 2016 | 19 | 2016 |
| Gene variants of adhesion molecules act as modifiers of disease severity in MS E Dardiotis, E Panayiotou, A Provatas, K Christodoulou, A Hadjisavvas, ... Neurology: Neuroimmunology & Neuroinflammation 4 (4), e350, 2017 | 18 | 2017 |
| Gene variants of adhesion molecules predispose to MS: A case-control study E Dardiotis, E Panayiotou, V Siokas, AM Aloizou, K Christodoulou, ... Neurology: Genetics 5 (1), e304, 2019 | 17 | 2019 |
| Pax6 is expressed in subsets of V0 and V2 interneurons in the ventral spinal cord in mice E Panayiotou, E Panayi, G Lapathitis, C Francius, F Clotman, N Kessaris, ... Gene Expression Patterns 13 (8), 328-334, 2013 | 17 | 2013 |
| Spatially distinct functions of PAX6 and NKX2. 2 during gliogenesis in the ventral spinal cord N Genethliou, E Panayiotou, H Panayi, M Orford, R Mean, G Lapathitis, ... Biochemical and biophysical research communications 382 (1), 69-73, 2009 | 17 | 2009 |
| Sequential role of SOXB2 factors in GABAergic neuron specification of the dorsal midbrain N Makrides, E Panayiotou, P Fanis, C Karaiskos, G Lapathitis, S Malas Frontiers in molecular neuroscience 11, 152, 2018 | 16 | 2018 |
| C1q ablation exacerbates amyloid deposition: a study in a transgenic mouse model of ATTRV30M amyloid neuropathy E Panayiotou, E Fella, R Papacharalambous, S Malas, MJ Saraiva, ... PloS one 12 (4), e0175767, 2017 | 14 | 2017 |
| Generation of an ABCG2GFPn-puro transgenic line–A tool to study ABCG2 expression in mice M Orford, R Mean, G Lapathitis, N Genethliou, E Panayiotou, H Panayi, ... Biochemical and biophysical research communications 384 (2), 199-203, 2009 | 14 | 2009 |
| Pharmacological stimulation of phagocytosis enhances amyloid plaque clearance; evidence from a transgenic mouse model of ATTR neuropathy E Fella, K Sokratous, R Papacharalambous, K Kyriacou, J Phillips, ... Frontiers in molecular neuroscience 10, 138, 2017 | 11 | 2017 |
| The frequency of central nervous system complications in the Cypriot cohort of ATTRV30M neuropathy transplanted patients E Dardiotis, S Andreou, AM Aloizou, E Panayiotou, V Siokas, MN Ioannou, ... Neurological Sciences 41, 1163-1170, 2020 | 10 | 2020 |
| A novel case of inclusion body myositis and myasthenia gravis S Lambrianides, E Kinnis, M Cleanthous, R Papacharalambous, ... Neuromuscular Disorders 29 (10), 771-775, 2019 | 5 | 2019 |
| Genetic background modifies amyloidosis in a mouse model of ATTR neuropathy E Panayiotou, R Papacharalambous, A Antoniou, G Christophides, ... Biochemistry and Biophysics Reports 8, 48-54, 2016 | 5 | 2016 |
| Pharmacological activation of the C5a receptor leads to stimulation of the β-adrenergic receptor and alleviates cognitive impairment in a murine model of familial Alzheimer’s … E Fella, R Papacharalambous, D Kynigopoulos, M Ioannou, R Derua, ... Frontiers in Immunology 13, 947071, 2022 | 2 | 2022 |
